¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"erythrocyte sensitizing substance"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • granulocyte-erythrocyte antigen
    °ú¸³±¸ÀûÇ÷±¸Ç׿ø
  • hyperchromic erythrocyte
    °í»ö¼ÒÀûÇ÷±¸
  • hypochromic erythrocyte
    Àú»ö¼ÒÀûÇ÷±¸
  • immature erythrocyte
    ¹Ì¼÷ÀûÇ÷±¸
  • median erythrocyte diameter
    Á¤ÁßÀûÇ÷±¸Áö¸§
  • normochromic erythrocyte
    Á¤»ó»ö¼ÒÀûÇ÷±¸, Á¤¿°ÀûÇ÷±¸
  • nucleated erythrocyte
    À¯ÇÙÀûÇ÷±¸
  • polychromatophilic erythrocyte
    ´Ù¿°ÀûÇ÷±¸, ¹µ»öÀûÇ÷±¸
  • spherical erythrocyte
    °ø¸ð¾çÀûÇ÷±¸, ±¸ÇüÀûÇ÷±¸
  • antibacterial substance
    Ç×±Õ¹°Áú
  • antifungal substance
    Ç×Áø±Õ¹°Áú
  • carcinogenic substance
    ¹ß¾Ï¹°Áú
  • cortical substance
    °ÑÁú, ÇÇÁú
  • crystalline substance
    °áÁ¤¹°Áú
  • cement substance
    Á¢ÇÕÁú, ½Ã¸àÆ®¹°Áú
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • erythrocyte sedimentation reaction
    ÀûÇ÷±¸Ä§°­¹ÝÀÀ
  • erythrocyte sedimentation test
    ÀûÇ÷±¸Ä§°­°Ë»ç
  • fragmented erythrocyte
    ºÐ¿­ÀûÇ÷±¸, Á¶°¢ÀûÇ÷±¸
  • frozen erythrocyte
    µ¿°áÀûÇ÷±¸
  • globulin-coated erythrocyte
    ±Û·ÎºÒ¸°ÇǸ·ÀûÇ÷±¸
  • hyperchromic erythrocyte
    °í»ö¼ÒÀûÇ÷±¸
  • hypochromic erythrocyte
    Àú»ö¼ÒÀûÇ÷±¸
  • immature erythrocyte
    ¹Ì¼÷ÀûÇ÷±¸
  • normochromic erythrocyte
    Á¤»ó»ö¼ÒÀûÇ÷±¸
  • nucleated erythrocyte
    À¯ÇÙÀûÇ÷±¸
  • orthochromatic erythrocyte
    È£»ê¼ºÀûÇ÷±¸
  • polychromatophilic erythrocyte
    ¹µ»öµëÀûÇ÷±¸, ´Ù¿°ÀûÇ÷±¸
  • spherical erythrocyte
    °ø¸ð¾çÀûÇ÷±¸, ±¸»óÀûÇ÷±¸
  • spiculated erythrocyte
    ¹Ù´ÃÀûÇ÷±¸, ħ»óÀûÇ÷±¸
  • free erythrocyte porphyrin
    À¯¸®ÀûÇ÷±¸Æ÷¸£ÇǸ°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • plasma membrane of erythrocyte
    ÀûÇ÷±¸ÇüÁú¸·
  • polychromatic erythrocyte
    ´Ù¿°¼ºÀûÇ÷±¸
  • polychromatophilic erythrocyte
    ¹µ»öµëÀûÇ÷±¸
  • C-substance
    C-¹°Áú.
  • EPS=£¾exophthalmos producing substance
    ¾È±¸µ¹ÃâÀ¯¹ß¹°Áú.
  • Goitrogenic substance
    °©»ó¼±Á¾À¯¹ß¹°Áú(Ë£ßÒàÍðþë¯Û¡Úªòõ)
  • Inducer substance
    À¯µµ¹°Áú(ë¯ÓôÚªòõ)
  • Inhibitor substance
    ¾ïÁ¦¹°Áú(åäð¤Úªòõ)
  • Kerry reducing substance test
    Äɸ®È¯¿ø¹°Áú½ÃÇè
  • Mullerian inhibiting substance
    ¹°·¯°ü ¾ïÁ¦¹°Áú
  • P substance
    P¹°Áú
  • SRS A : slow reacting substance A
    ¿¡½º¾Ë¿¡½º-¿¡ÀÌ.
  • accelerans substance
    ÃËÁø¹°Áú(õµòäÚªòõ).
  • accessory food substance
    ºÎ¿µ¾ç¹°(Üùç½å×Úª).
  • acrosomal substance
    ÷´Üü¹°Áú
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • erythrocyte
    ÀûÇ÷±¸
  • erythrocyte
    ÀûÇ÷±¸
  • erythrocyte antibody test
    ÀûÇ÷±¸Ç×ü½ÃÇè
  • erythrocyte antigen
    ÀûÇ÷±¸Ç׿ø
  • erythrocyte antigen test
    ÀûÇ÷±¸Ç׿ø½ÃÇè
  • erythrocyte appearance
    ÀûÇ÷±¸¸ð¾ç
  • erythrocyte balance
    ÀûÇ÷±¸ÆòÇü
  • erythrocyte cast
    ÀûÇ÷±¸¿øÁÖ
  • erythrocyte counting
    ÀûÇ÷±¸°è»ê
  • erythrocyte damage
    ÀûÇ÷±¸¼Õ»ó
  • erythrocyte destruction
    ÀûÇ÷±¸ÆÄ±«
  • erythrocyte enzyme deficiency
    ÀûÇ÷±¸È¿¼Ò°áÇÌÁõ
  • erythrocyte freezing
    ÀûÇ÷±¸³Ãµ¿
  • erythrocyte ghost
    ÀûÇ÷±¸Çã±úºñ
  • erythrocyte globulin induction
    ÀûÇ÷±¸±Û·ÎºÒ¸°À¯µµ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • White substance
    ¹é»öÁú
    [¿¾ ¿ë¾î] ¹éÁú
  • Cortical substance
    »À°ÑÁú
    [¿¾ ¿ë¾î] ÇÇÁú
  • Fibrinoid substance
    ¼¶À¯¼Ò¼º¹°Áú
    [¿¾ ¿ë¾î] À¯¼¶À¯¼ÒÁú
  • Reticular substance
    ¼¼¸ÁÁú
    [¿¾ ¿ë¾î] ¼¼¸ÁÁú
  • Intercellular substance
    ¼¼Æ÷»çÀ̹°Áú
    [¿¾ ¿ë¾î] ¼¼Æ÷°£Áú
  • Intercellular substance
    ¼¼Æ÷»çÀ̹°Áú
    [¿¾ ¿ë¾î] ½Ã¸àÆ®Áú¼¼Æ÷°£Áú
  • Lens substance
    ¼öÁ¤Ã¼¹°Áú
    [¿¾ ¿ë¾î] ¼öÁ¤Ã¼Áú
  • Neurosecretory substance
    ½Å°æºÐºñ¹°
    [¿¾ ¿ë¾î] ½Å°æºÐºñ¹°
  • Gelatinous substance
    ¾Æ±³Áú
    [¿¾ ¿ë¾î] ±³¾çÁú
  • Anterior perforated substance
    ¾Õ°üÅëÁú
    [¿¾ ¿ë¾î] ÀüÀ¯°øÁú
  • Central gelatinous substance
    Á߽ɾƱ³Áú
    [¿¾ ¿ë¾î] Á߽ɱ³¾çÁú
  • Central intermediate substance
    Áß½ÉÁß°£È¸»öÁú
    [¿¾ ¿ë¾î] Áß°£ÁúÁ߽ɺÎ
  • Central gray (substance)
    Áß½Éȸ»öÁú
    [¿¾ ¿ë¾î] Áß½Éȸ¹éÁú
  • Postacrosomal substance
    ÷´ÜüµÚ¹°Áú
    [¿¾ ¿ë¾î] ÷´ÜüÈŰÁú
  • Postacrosomal substance
    ÷´ÜüµÚ¹°Áú
    [¿¾ ¿ë¾î] ÷´ÜüÈÄÁú
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
SSA salicylsalicylic acid; sicca syndrome A; skin-sensitizing antibody; skin sympathetic activity; Sjogr...
MIS management information system; medical information service; meiosis-inducing substance; minimally in...
ESR Erythrocyte Sedimentation Rate; 0 - 30 mm/Hr(¿µ¾Æ)
FEP Free Erythrocyte (Proto)Porphyrins
SER   1) Smooth Endoplasmic Reticulum
  2) Sedimentation Erythrocyte Rate
&nbs...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
EA Erythrocyte antibody
EAC Erythrocyte antibody complement
ETK Erythrocyte transketolase
ETKA Erythrocyte transketolase activity
FEP Free erythrocyte porphyrins
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • ascending substance P
    »óÇà P ¹°Áú
  • bone inducing substance
    °ñ Çü¼º À¯µµ ÀÎÀÚ
  • bone substance
    °ñÁú
  • cement substance
    Á¢ÇÕ ¹°Áú
    µÎ °³ÀÇ Ç¥¸éÀ» °ß°íÇÏ°Ô Á¢ÇÕÇÏ´Â ¹°Áú.
  • coagualtion-active substance
    ÀÀ°í Ȱ¼º ¹°Áú
  • corrosive substance
    ºÎ½Ä ¹°Áú, ºÎ½Ä¼º ¹°Áú
  • cytotoxic substance
    ¼¼Æ÷ µ¶, ¼¼Æ÷µ¶¼Ò
    µ¿ÀǾî=cytotoxin.
  • endobiotic substance
    ³»»ýÀû ¹°Áú
  • ferromagnetic substance
    öÀÚ¼º ü, °­ÀÚ¼º ü
  • intercelluar substance
    ¼¼Æ÷°£ ¹°Áú
  • intercellular substance
    ¼¼Æ÷ °£Áú, ¼¼Æ÷°£ ¹°Áú
    ¼¼Æ÷¿Í ¼¼Æ÷ »çÀ̸¦ ä¿ì´Â ¹°Áú. ±âÁúÀ̶ó°íµµ ÇÑ´Ù. ÁÖµÈ ¼ººÐÀº È÷¾Ë¿ì·Ð»êÀ̳ª Äܵå·ÎÀÌÆ¾ Ȳ»ê µîÀÇ Á¡¾× ´Ù´çÀ» ÁÖ·ÎÇÏ´Â ´Ü¹éÁú ´Ù´çÀÌ´Ù. »À Á¶Á÷¿¡¼­´Â Ä®½· ¿°, ¸¶±×³×½· ¿°À» ¼¼Æ÷°£ ¹°Áú·Î¼­ ÇÔÀ¯Çϰí ÀÖ´Ù.
  • lateral intermediate substance
    °¡ÂÊ Áß°£ ȸ»öÁú
  • lens substance
    ¼öÁ¤Ã¼ ¹°Áú, ¼öÁ¤Ã¼ Áú
  • medullary substance
    ¼öÁú
    Ãà»è°ú ¼öÃʸ¦ ÀÌ·ç´Â ÁßÃ߽Űæ°èÀÇ ¹éÁú. ±â°ü ³»ºÎÀÇ À¯¿¬ÇÑ °ñ¼ö¾ç ¹°Áú.
  • nutrient substance
    ¿µ¾ç ¹°Áú
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
erythrocyte maturation factor <biochemistry> Member of the water soluble B vitamin group, important in the proper function of the nervous system and important in proper carbohydrate, protein and fat metabolism.
(27 Sep 1997)
erythrocyte membrane The semipermeable outer portion of the red corpuscle. It is known as a 'ghost' after haemolysis.
(12 Dec 1998)
erythrocyte membrane protein band 4.1 See Elliptocytosis.
(12 Dec 1998)
erythrocyte sedimentation rate <investigation> A test that measures the rate at which red blood cells settle through a column of liquid. A non-specific index of inflammation.
Acronym: ESR
(11 Nov 1997)
erythrocyte transfusion The transfer of erythrocytes from a donor to a recipient or reinfusion to the donor.
(12 Dec 1998)
erythrocyte volume Volume of circulating erythrocytes. It is usually measured by radioisotope dilution technique.
(12 Dec 1998)
alpha substance A filamentous plasmatic material, beaded with granules, demonstrable by means of vital staining in the immature red blood cells.
Synonym: alpha substance, filar mass, filar substance, substantia reticularis, substantia reticulofilamentosa.
Synonym: reticular formation.
(05 Mar 2000)
anterior perforated substance A region at the base of the brain through which numerous small branches of the anterior and middle cerebral arteries (lenticulostriate arteries) enter the depth of the cerebral hemisphere; it is bordered medially by the optic chasm and anterior half of the optic tract, rostrally and laterally by the lateral olfactory stria; its anteromedial part corresponds to the olfactory tubercle.
Synonym: substantia perforata anterior, locus perforatus anticus, olfactory area.
(05 Mar 2000)
autacoid substance A substance formed metabolically by one set of cells, which alters the function of other cells. (This term is sometimes used in place of the term hormone.)
(05 Mar 2000)
bacteriotropic substance Opsonin or other substance that alters bacterial cells in such a manner that they are more susceptible to phagocytic action.
(05 Mar 2000)
basophilic substance The material consisting of granular endoplasmic reticulum and ribosomes that occurs in nerve cell bodies and dendrites.
Synonym: basophil substance, basophilic substance, chromophil substance, Nissl bodies, Nissl granules, substantia basophilia, tigroid bodies, tigroid substance.
(05 Mar 2000)
basophil substance The material consisting of granular endoplasmic reticulum and ribosomes that occurs in nerve cell bodies and dendrites.
Synonym: basophil substance, basophilic substance, chromophil substance, Nissl bodies, Nissl granules, substantia basophilia, tigroid bodies, tigroid substance.
(05 Mar 2000)
blood group substance Blood group-specific substances A and B, solution of complexes of polysaccharides and amino acids that reduces the titre of anti-A and anti-B isoagglutinins in serum from group O persons; used to render group O blood reasonably safe for transfusion into persons of group A, B, or AB, but does not affect any incompatibility that results from various other factors, such as Rh.
(05 Mar 2000)
vasodepressor substance An incompletely characterised chemical, apparently produced during liver damage, that tends to decrease vascular pressures and relax arterial walls.
(05 Mar 2000)
gelatinous substance The apical part of the posterior horn (dorsal horn; posterior gray column) of the spinal cord's gray matter, composed largely of very small nerve cells; its gelatinous appearance is due to its very low content of myelinated nerve fibres.
Synonym: substantia gelatinosa, Rolando's gelatinous substance, Rolando's substance.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á